1.
C.H. Kim, and Y.S. Ahn (1997) Nitric oxide
prevents the bovine cerebral endothelial
cell death induced by serum deprivation.
Korean J. Physiol. Pharmacol. 1, 515-521
2. C.H. Kim, J.H. Kim, J. Xu, C.Y. Hsu,
and Y.S. Ahn (1999) Pyrrolidine dithiocarbamate
induces bovine cerebral endothelial cell
death by increasing intracellular zinc level.
J. Neurochem. 72, 1586-1592
3. C.H. Kim, J.H. Kim, C.Y. Hsu, and Y.S.
Ahn (1999) Zinc is required in pyrrolidine
dithiocarbamate inhibition of nuclear factor
kappa B (NF-kappaB). FEBS Lett. 449, 28-32
4. C.H. Kim, J.H. Kim, S.J. Moon, K.C.
Chung, C.Y. Hsu, J.T. Seo, and Y.S. Ahn
(1999) Pyrithione, a zinc ionophore, inhibits
NF-kappaB activation. Biochem. Biophys.
Res. Commun. 259, 505-509
5. K.C. Chung, J.H. Park, C.H. Kim, and
Y.S. Ahn (1999) Tumor necrosis factor alpha
and PMA differentially modulate cytotoxic
effect of nitric oxide generated by serum
deprivation in neuronal PC12 cells. J. Neurochem.
72, 1482-1488
6. C. Choi, J.Y. Park, J. Lee, J. Lim,
E. Shin, Y.S. Ahn, C.H. Kim, S. Kim, J.
Kim, I.S. Choi, and I. Choi. (1999) FasL
and Fas are expressed constitutively in
human astrocytes and the expression increases
with IL-1, IL-6, TNF-alpha or IFN-gammaJ.
Immunol. 162, 1889-1895
7. C.H. Kim, J.H. Kim, S.J. Moon, C.Y.
Hsu, J.T. Seo, and Y.S. Ahn (1999) Biphasic
effects of dithiocarbamates on the activity
of NF-kappaB. Eur. J. Pharmacol. 392, 133-136
8. Y.S. Ahn, C.H. Kim, and J.H. Kim (1999)
Role of protein kinases on NF-kappaB activation
and cell death in bovine cerebral endothelial
cells. Korean J. Physiol. Pharmacol. 3,
11-18
9. K.C. Chung, J.H. Park, C.H. Kim, H.W.
Lee, N. Sato, Y. Uchiyama, and Y.S. Ahn
(2000) Novel biphasic effect of pyrrolidine
dithiocarbamate on neuronal cell viability
is mediated by the differential regulation
of intracellular zinc and copper ion levels,
NF-kappaB and MAP kinases. J. Neurosci.
Res. 59, 117-125
10. S. Baek, J. Kim, J. Choi, E. Park,
M. Han, C.H. Kim, Y.S. Ahn, and Y. Park
(2000) Reduced glutathione oxidation ratio
and 8 ohdG accumulation by mild ischemic
pretreatment. Brain Res. 856, 28-36
11. E.C. Shin, J.M. Ahn, C.H. Kim, Y. Choi,
Y.S. Ahn, H. Kim, S.J. Kim, and J.H. Park
(2001) Interferon-gamma induces cell death
in human hepatoma cells through a TRAIL/death
receptor-mediated apoptotic pathway. Int.
J. Cancer 93, 262-268.
12. E.C. Shin, Y.R. Seong, C.H. Kim, H.
Kim, Y.S. Ahn, K. Kim, S.J. Kim, S. Hong,
and J.H. Park (2002) Human hepatocellular
carcinoma cells resist to TRAIL-induced
apoptosis, and the resistance is abolished
by cisplatin. Exp. Mol. Med. 34, 114-122
13. C.H. Kim, J.H. Kim, J. Lee, C.Y. Hsu,
and Y.S. Ahn (2003) Thiol antioxidant reversal
of pyrrolidine dithiocarbamate-induced reciprocal
regulation of AP-1 and NF-kappaB. Biol.
Chem. 384, 143-150
14. J. Lee, C.H. Kim, K.D. Shim, and Y.S.
Ahn (2003) Inhibition of NF-kappaB activation
increases oxygen-glucose deprivation-induced
cerebral endothelial cell death. Korean
J. Physiol. Pharmacol. 7, 65-71
15. C.H. Kim, J.H. Kim, J. Lee, and Y.S.
Ahn (2003) Zinc-induced NF-kappaB inhibition
can be modulated by changes in intracellular
metallothionein level. Toxicol. Appl. Pharmacol.
190, 189-196
16. D.Y. Park, M.Y. Sol, K.S. Suh, E.C.
Shin, and C.H. Kim (2003) Expression of
transforming growth factor (TGF)-beya1 and
TGF-beta type II receptor and their relationship
with apoptosis during chemical hepatocarcinogenesis
in rats. Hepatol. Res. 27, 205-213
17. I. Kim*, C.H. Kim*, J.H. Kim, J. Lee,
J.J. Choi, M.G. Lee, K.C. Chung, C.Y. Hsu,
and Y.S. Ahn (2004) Pyrrolidine dithiocarbamate
and zinc inhibit proteasome-dependent proteolysis.
Exp. Cell Res. 298, 229-238(*equal contribution)
18. C.H. Kim, B. Stephanie, J.T.R. Isaac,
and K.W. Roche (2005) Protein kinase C phosphorylation
of the metabotropic glutamate receptor mGluR5
on serine 839 regulates Ca2+ oscillations.
J. Biol. Chem. 280, 25409-25415
19. J.H. Lee, J. Lee, G.H. Seo, C.H. Kim,
and Y.S. Ahn (2007) Heparin inhibits NF-kappaB
activation and increases cell death in cerebral
endothelial cells after oxygen-glucose deprivation.
J. Mol. Neurosci. 32(2), 145-154
20. C.H. Kim*, J. Lee, J. Lee, K.W. Roche
(2008) Metabotropic glutamate receptors:
phosphorylation and receptor signaling.
J. Neurosci. Res. 86, 1-10 (*corresponding
author)
21. E.S. Kang, G.T. Lee, B.S. Kim, C.H.
Kim, G.H. Seo, S.J. Han, K.Y. Hur, C.W.
Ahn, H. Ha, M. Jung, Y.S. Ahn, B.S. Cha,
H.C. Lee (2008) Lithospermic acid B ameliorates
the development of diabetic nephropathy
in OLETF rats. Eur. J. Pharmacol. 579, 418-425
22. E.S. Kang, M.S. Kim, Y.S. Kim, C.H.
Kim, S.J. Han, S.W. Chun, K.Y. Hur, C.M.
Nam, C.W. Ahn, B.S. Cha, S.I. Kim, H.C.
Lee (2008) A Polymorphism in the Zinc Transporter
Gene, SLC30A8, Confers Resistance Against
Posttransplantation Diabetes Mellitus in
Renal Allograft Recipients. Diabetes 58,
1043-1047
23. I. Kim*, C.H. Kim*, G.H. Seo, H.S.
Kim, J. Lee, D.G. Kim, Y.S. Ahn (2008) Inhibitory
effect of zinc on hypoxic HIF-1 activation
in astrocytes. Neuroreport, 19, 1065-1068
(*equal contribution)
24. J.H. Lee, J. Lee, K.Y. Choi, R. Hepp,
J. Lee, M.K. Lim, M. Chatani-Hinze, P.A.
Roche, D.G. Kim, Y.S. Ahn, C.H. Kim*, K.W.
Roche (2008) Calmodulin dynamically regulates
the trafficking of the metabotropic glutamate
receptor mGluR5, Proc. Natl. Acad. Sci.
USA, 105, 12575-12580 (*corresponding author)
25. I. Kim, C.H. Kim, Y.S. Yim, Y.S. Ahn
(2008) Autocrine function of erythropoietin
in IGF-1-induced erythropoietin biosynthesis.
Neuroreport 19, 1699-1703
26. Y.H. Lee, E.S. Kang, S.H. Kim, S.J.
Han, C.H. Kim, C.W. Ahn, B.S. Cha, M, Nam,
C.M. Nam, H.C. Lee (2008) Association between
polymorphisms in SLC30A8, HHEX, CDKN2A/B,
IGF2BP2, FTO, WFS1, CDKAL1, KCNQ1 and type
2 diabetes in the Korean population. J.
Hum. Genet. 53, 991-998
27. J.H. Lee, C.H. Kim, G.H. Seo, J. Lee,
J.H. Kim, D.G. Kim, Y.S. Ahn (2008) Heparin
Attenuates the _Expression of TNF¥á-induced
Cerebral Endothelial Cell Adhesion Molecule.
Korean J. Physiol. Pharmacol. 12, 231-236
28. J.H. Lee, C.H. Kim, D.G. Kim, Y.S.
Ahn (2009) Microarray analysis of differentially
expressed genes in the brains of tubby mice.
Korean J. Physiol. Pharmacol. 13, 91-97
29. J. Lee*, C.H. Kim*, D.G. Kim, Y.S.
Ahn (2009) Zinc inhibits amyloid ? production
from Alzheimer¡¯s amyloid precursor protein
in SH-SY5Y cells. Korean J. Physiol. Pharmacol.
13, 195-200 (*equal contribution)
30. Y.S. Yim, J. Choi, S.B. Jang, G.T.
Kim, K. Park, C.H. Kim, J. Cheon, D.G. Kim
(2009) Pharmacokinetic properties and tissue
storage of FITC-conjugated SA-MnMEIO nanoparticles
in mice. Current Applied Physics 9, e304-e307
31. Y.H. Hong, J.Y. Kim, J.H. Lee, H.G.
Chae, S.S. Jang, J.H. Jeon, C.H. Kim, J.
Kim, S.J. Kim (2009) Agonist-induced internalization
of mGluR1? is mediated by caveolin. J. Neurochem.
111, 61-71
32. E.S. Kang, M.S. Kim, C.H. Kim, C.M.
Nam, S.J. Han, K.Y. Hur, C.W. Ahn, B.S.
Cha, S.I. Kim, H.C. Lee, Y.S. Kim (2009)
Association of common type 2 diabetes risk
gene variants and posttransplantation diabetes
mellitus in renal allograft recipients in
Korea. Transplantation 88, 693-698
33. J.Y. Kwon, S.W. Bai, Y.G. Kwon, S.H.
Kim, C.H. Kim, M.H. Kang, J.A. Linton, Y.W.
Park (2010) The effect of nicotine on the
production of soluble fms-like tyrosine
kinase-1 and soluble endoglin in human umbilical
vein endothelial cells and trophoblasts.
Acta. Obstet. Gynecol. Scand. 89, 565-571
34. I.S. Kim, E.S. Kang, Y.S. Yim, S.J.
Ko, S. Jeong, J.H. Rim, Y.S. Kim, C.W. Ahn,
B.S. Cha, H.C. Lee, C.H. Kim (2010) A low-risk
ZnT-8 allele (W325) for post-transplantation
diabetes mellitus is protective against
cyclosporin A-induced impairment of insulin
secretion. Pharmacogenomics J. in press
|